Stockreport

PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial

PMV Pharmaceuticals, Inc.  (PMVP) 
PDF Enrollment on track in registrational Phase 2 portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type adva [Read more]